FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Teresa Moran

Research Profile

Disorders

Chemicals & Drugs

Physiology

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Niki Karachaliou; Margarita Majem; Bartomeu Massuti; Clara Mayo; Miguel Angel Molina-Vila; Teresa Moran; Rafael Rosell; Jose Javier Sanchez; John Souglakos; Santiago Viteri; Luciano Wannesson; Jordi Bertran-Alamillo; Enric Carcereny; Carlota Costa; Amaya Gasco; Ana Gimenez-Capitan; Jose Jimeno
BRCA1, LMO4, and CtIP mRNA expression in erlotinib-treated non-small-cell lung cancer patients with EGFR mutations.
Fernanda Salazar; Miguel Angel Molina; Maria Sanchez-Ronco; Teresa Moran; Jose Luis Ramirez; Jose Miguel Sanchez; Rolf Stahel; Pilar Garrido; Manuel Cobo; Dolores Isla; Jordi Bertran-Alamillo; Bartomeu Massuti; Felipe Cardenal; Christian Manegold; Pilar Lianes; José M Trigo; Jose Javier Sanchez; Miquel Taron; Rafael Rosell
First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients.
Rafael Rosell; Teresa Moran; Santiago Viteri; Enric Carcereny; Amaya Gasco; Vanessa Quiroga; Jia Wei; Carlos Camps; Bartomeu Massuti
Optimization of genetics to create therapies for metastatic (stage IV) non-small-cell lung cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Teresa Moran (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Niki Karachaliou; Margarita Majem; Bartomeu Massuti; Clara Mayo; Miguel Angel Molina-Vila; Teresa Moran; Rafael Rosell; Jose Javier Sanchez; John Souglakos; Santiago Viteri; Luciano Wannesson; Jordi Bertran-Alamillo; Enric Carcereny; Carlota Costa; Amaya Gasco; Ana Gimenez-Capitan; Jose Jimeno
BRCA1, LMO4, and CtIP mRNA expression in erlotinib-treated non-small-cell lung cancer patients with EGFR mutations.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2013;8(3):295-300.
2011: Fernanda Salazar; Miguel Angel Molina; Maria Sanchez-Ronco; Teresa Moran; Jose Luis Ramirez; Jose Miguel Sanchez; Rolf Stahel; Pilar Garrido; Manuel Cobo; Dolores Isla; Jordi Bertran-Alamillo; Bartomeu Massuti; Felipe Cardenal; Christian Manegold; Pilar Lianes; José M Trigo; Jose Javier Sanchez; Miquel Taron; Rafael Rosell
First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients.
Lung cancer (Amsterdam, Netherlands) 2011;72(1):84-91.
2010: Rafael Rosell; Teresa Moran; Santiago Viteri; Enric Carcereny; Amaya Gasco; Vanessa Quiroga; Jia Wei; Carlos Camps; Bartomeu Massuti
Optimization of genetics to create therapies for metastatic (stage IV) non-small-cell lung cancer.
Expert opinion on pharmacotherapy 2010;11(10):1683-93.
2010: Enric Carcereny; Jose Luis Ramirez; Maria Sanchez-Ronco; Dolores Isla; Manuel Cobo; Teresa Moran; Itziar de Aguirre; Tatsuro Okamoto; Jia Wei; Mariano Provencio; Guillermo Lopez-Vivanco; Carlos Camps; Manuel Domine; Vicente Alberola; Jose Miguel Sanchez; Bartomeu Massuti; Pedro Méndez; Miquel Taron; Rafael Rosell
Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients.
Lung cancer (Amsterdam, Netherlands) 2010;68(3):491-7.
2010: I Garcia-Olivé; Eduard Monsó; Felipe Andreo; J Sanz-Santos; Miquel Taron; M A Molina-Vila; Mariona Llatjós; Eva Castellà; Teresa Moran; J Bertran-Alamillo; C Mayo-de-Las-Casas; C Queralt; Rafael Rosell
Endobronchial ultrasound-guided transbronchial needle aspiration for identifying EGFR mutations.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2010;35(2):391-5.
2010: Sara Simonetti; Miguel Angel Molina; Cristina Queralt; Itziar de Aguirre; Clara Mayo; Jordi Bertran-Alamillo; José Javier Sanchez; Jose Luis Gonzalez-Larriba; Ulpiano Jimenez; Dolores Isla; Teresa Moran; Santiago Viteri; Carlos Camps; Rosario Garcia-Campelo; Bartomeu Massuti; Susana Benlloch; Miquel Taron; Santiago Ramon y Cajal; Rafael Rosell
Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer.
Journal of translational medicine 2010;8():135.
2009: Rafael Rosell; Teresa Moran; Cristina Queralt; Rut Porta; Felipe Cardenal; Carlos Camps; Margarita Majem; Guillermo Lopez-Vivanco; Dolores Isla; Mariano Provencio; Amelia Insa; Bartomeu Massuti; Jose Luis Gonzalez-Larriba; Luis Paz-Ares; Isabel Bover; Rosario Garcia-Campelo; Miguel Angel Moreno; Silvia Catot; Christian Rolfo; Noemi Reguart; Ramon Palmero; José Miguel Sánchez; Roman Bastus; Clara Mayo; Jordi Bertran-Alamillo; Miguel Angel Molina; Jose Javier Sanchez; Miquel Taron
Screening for epidermal growth factor receptor mutations in lung cancer.
The New England journal of medicine 2009;361(10):958-67.
2009: Rafael Rosell; Laia Perez-Roca; Jose Javier Sanchez; Manuel Cobo; Teresa Moran; Imane Chaib; Mariano Provencio; Manuel Domine; Maria Angeles Sala; Ulpiano Jimenez; Pilar Diz; Isidoro Barneto; Jose Antonio Macias; Ramon de las Peñas; Silvia Catot; Dolores Isla; Jose Miguel Sanchez; Rafael Ibeas; Guillermo Lopez-Vivanco; Juana Oramas; Pedro Méndez; Noemi Reguart; Remei Blanco; Miquel Taron
Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression.
PloS one 2009;4(5):e5133.
2008: Miguel A Molina-Vila; Jordi Bertran-Alamillo; Noemí Reguart; Miquel Taron; Eva Castellà; Mariona Llatjós; Carlota Costa; Clara Mayo; Anna Pradas; Cristina Queralt; Mónica Botia; María Pérez-Cano; Esther Carrasco; Mireia Tomàs; Jose Luis Mate; Teresa Moran; Rafael Rosell
A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cells.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(11):1224-35.
2008: Rafael Rosell; Rolf Stahel; Jose Manuel Trigo; Jia Wei; Remei Blanco; Pilar Garrido; Pilar Lianes; Christian Manegold; Teresa Moran; Miquel Taron
Can we customize chemotherapy? Individualizing cytotoxic regimens in advanced non-small-cell lung cancer.
Clinical lung cancer 2008;9 Suppl 2():S76-82.
2007: Eva Martinez-Balibrea; Jose Luis Manzano; Anna Martinez-Cardus; Teresa Moran; Beatriz Cirauqui; Silvia Catot; Miquel Taron; Albert Abad
Combined analysis of genetic polymorphisms in thymidylate synthase, uridine diphosphate glucoronosyltransferase and X-ray cross complementing factor 1 genes as a prognostic factor in advanced colorectal cancer patients treated with 5-fluorouracil plus oxaliplatin or irinotecan.
Oncology reports 2007;17(3):637-45.
2006: Rafael Rosell; Miquel Taron; Noemi Reguart; Dolores Isla; Teresa Moran
Epidermal growth factor receptor activation: how exon 19 and 21 mutations changed our understanding of the pathway.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7222-31.
2006: Rafael Rosell; Teresa Moran; M Fernanda Salazar; Pedro Méndez; Itziar de Aguirre; José Luis Ramirez; Dolores Isla; Manuel Cobo; Carlos Camps; Guillermo Lopez-Vivanco; Vicente Alberola; Miquel Taron
The place of targeted therapies in the management of non-small cell bronchial carcinoma. Molecular markers as predictors of tumor response and survival in lung cancer.
Revue des maladies respiratoires 2006;23(5 Pt 3):16S131-16S136.
2005: José Luis Ramirez; Rafael Rosell; Miquel Taron; Maria Sanchez-Ronco; Vicente Alberola; Ramon de las Peñas; Jose Miguel Sanchez; Teresa Moran; Carlos Camps; Bartomeu Massuti; Jose Javier Sanchez; Fernanda Salazar; Silvia Catot
14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9105-12.
2005: Rafael Rosell; Manuel Cobo; Dolores Isla; Jose Miguel Sanchez; Miquel Taron; Giuseppe Altavilla; Mariacarmela Santarpia; Teresa Moran; Silvia Catot; Olatz Etxaniz
Applications of genomics in NSCLC.
Lung cancer (Amsterdam, Netherlands) 2005;50 Suppl 2():S33-40.
2005: Rafael Rosell; Yukito Ichinose; Miquel Taron; Carme Sarries; Cristina Queralt; Pedro Méndez; Jose Miguel Sanchez; Ken-Ichi Nishiyama; Teresa Moran; Beatriz Cirauqui; José-Luis Mate; Benjamin Besse; Noemi Reguart; Maria Perez; Jose Javier Sanchez
Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2005;50(1):25-33.
2005: Miquel Taron; Yukito Ichinose; Rafael Rosell; Tony Shu Kam Mok; Bartomeu Massuti; Lurdes Zamora; José-Luis Mate; Christian Manegold; Mayumi Ono; Cristina Queralt; Thierry jahan; Jose Javier Sanchez; Maria Sanchez-Ronco; Victor Hsue; David M Jablons; Jose Miguel Sanchez; Teresa Moran
Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):5878-85.
2005: Rafael Rosell; Enriqueta Felip; Noemi Reguart; Teresa Moran
Crossing the rubicon in lung adenocarcinoma: the conundrum of EGFR tyrosine kinase mutations.
Future oncology (London, England) 2005;1(3):319-22.
2004: Rafael Rosell; Miquel Taron; Jose Miguel Sanchez; Teresa Moran; Noemi Reguart; Benjamin Besse; Dolores Isla; Bartomeu Massuti; Vicente Alberola; Jose Javier Sanchez
The promise of pharmacogenomics: gemcitabine and pemetrexed.
Oncology (Williston Park, N.Y.) 2004;18(13 Suppl 8):70-6.
2004: Rafael Rosell; Jose Miguel Sanchez; Miquel Taron; Teresa Moran; Beatriz Ciuraqui; Mercedes Canela; Enriqueta Felip; Bartomeu Massuti; Carlos Camps
Pemetrexed in previously treated non-small-cell lung cancer.
Oncology (Williston Park, N.Y.) 2004;18(8 Suppl 5):63-71.